Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

XP13512 (GSK1838262) Versus Placebo in Patients With Restless Legs Syndrome.

This study has been completed.
Sponsor:
Information provided by:
XenoPort, Inc.
ClinicalTrials.gov Identifier:
NCT00298623
First received: February 28, 2006
Last updated: May 10, 2013
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2007
  Primary Completion Date: February 2007 (Final data collection date for primary outcome measure)
No publications provided by XenoPort, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):